同德化工(002360.SZ):2023年度淨利潤預增121.77%-170.68%
格隆匯1月29日丨同德化工(002360.SZ)公佈2023年度業績預吿,報吿期歸屬於上市公司股東的淨利潤盈利40,800.00萬元–49,800.00萬元,比上年同期增長121.77%-170.68%;扣除非經常性損益後的淨利潤盈利14,800.00萬元–18,100.00萬元,比上年同期增長-20.30%--2.52%;基本每股收益盈利1.02元/股–1.24元/股。
報吿期內,公司主業民爆業務穩步向好,安全生產經營態勢良好。2023年度歸屬於上市公司股東的淨利潤較2022年度大幅增長主要原因:公司轉讓全資子公司廣靈同德100%股權及同蒙化工100%股權對淨利潤的影響金額約為38,573.00萬元,屬於非經常性損益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.